Do GLP-1 patches, drops and supplements work?
No. No patch, drop or supplement is an approved GLP-1 medicine. Approved semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are prescription injections or tablets. When Australia's regulator tested drops and liquids labelled as GLP-1, it found no GLP-1 in them. A 2026 review found "GLP-1" patches listed plant and nutrient ingredients.
Is any GLP-1 patch, drop or supplement an approved medicine?
No. In the regulator pages we checked, approved GLP-1 medicines are prescription injections or tablets, never a patch, drop or supplement.1,2
Health Canada says semaglutide and tirzepatide are prescription drugs that come “in either injectable formats or as oral tablets”.1 The European Medicines Agency describes Wegovy as pens for injection and tablets, available only with a prescription.2
On skin products, the US Federal Trade Commission says, “Nothing you can wear or apply to your skin will cause you to lose weight. Period.”3
How hard is it to get a GLP-1 medicine into the body without an injection?
Very hard. Even the approved semaglutide tablet needs an added absorption helper, and only about 1% of each dose reaches the blood.4,5
The helper is salcaprozate sodium (SNAC). The US Rybelsus label says it “facilitates the absorption” of semaglutide, and puts absorption at 0.4% to 1%.4 The EU and UK product information give about 1%.5,6
The UK product information adds that absorption “is highly variable and may be minimal”.6 The EU label says to take the tablet once a day on an empty stomach, with up to half a glass of water (120 mL).5
What did tests and reviews find inside these products?
Australia's regulator, the TGA, tested imported drops and oral liquids labelled as GLP-1, and found no GLP-1 or GLP-1 analogue in them.7
The RACGP's newsGP reported the result in March 2026. The products carried names such as “slimming and health boost drops”.7
A 2026 review in the Annals of Pharmacotherapy looked at 24 “natural GLP-1” patches and 1 gel. Each listed about 7 ingredients, most often berberine, glutamine, cinnamon and pomegranate.8 None posted a certificate of analysis (an independent lab result), and many used deceptive advertising.8
Health Canada warns that unauthorised GLP-1 products can hold “too much, too little, or none of the active ingredient”. They can also hold unlisted or dangerous ingredients.1
Is berberine a “natural GLP-1”?
No. Berberine is among the most common “GLP-1” patch ingredients, and NIH says the evidence that it helps weight loss is not conclusive.8,9
NIH's complementary health centre describes a 2022 review. It found lower weight mainly at doses over 1 gram a day for more than 8 weeks, and many of its studies had a high risk of bias.9
Berberine has harms too. NIH lists nausea, stomach pain, bloating, constipation and diarrhoea. It interacts with cyclosporine, a transplant medicine, and may be unsafe in pregnancy or breastfeeding.9
What do people on GLP-1 medicines report about patches and supplements?
From public patient forums: 56 Reddit threads in r/Zepbound, r/glp1, r/WegovyWeightLoss, r/Semaglutide, r/mounjarouk and r/Mounjaro, read from October 2025 to October 2026. Personal reports, not medical evidence.
What people describe
- Matches Health Canada Several say no real GLP-1 patch exists, and that approved GLP-1s come only as injections or tablets.1
- Matches the review Several say patches list ordinary supplement ingredients, such as berberine, cinnamon and amino acids.8
- Matches NIH Several say berberine did little or nothing for their weight, while a few felt it helped slightly. NIH says the evidence on weight is not conclusive.9
- Matches NIH Several describe bloating, diarrhoea or nausea after these products. NIH lists the same gut symptoms as side effects of berberine.9
- Matches Health Canada Several suspect that upbeat posts and reviews are promotion, pointing to influencers and doctored photos. Health Canada says some GLP-1 adverts display fake endorsements.1
Advice people share
- Matches NIH Several warn that “natural” does not mean harmless, and to check interactions. NIH says berberine interacts with cyclosporine, a transplant medicine.9
- Health Canada says otherwise Several mention research peptides or grey-market GLP-1s. Health Canada says not to buy or use unauthorised GLP-1 products, which may hold too much, too little or none of the medicine.1
- Matches Health Canada A few suggest reporting misleading adverts. Health Canada asks people to report complaints, including suspected unauthorised products.1
In your country
In every country we cover, the GLP-1 medicines sold are prescription injections or tablets; what differs is the brand list.
Australia
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: none (Wegovy pill treated as not approved). Semaglutide tablets, diabetes: Rybelsus approved; whether supplied not confirmed.
Label: The answer above applies. We could not open the TGA's own advisory page, so the test result comes from newsGP's report of it.7 The tablet figures come from the EU and US labels, as we did not open Australia's.4,5
Emergency number: 000
Fake and unregulated products, in the Australian side-effects guide
Canada
Sold as: Tirzepatide: Mounjaro, Mounjaro KwikPen, Zepbound. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic; Semaglutide Injection (Dr. Reddy’s; shortage reported Jul 2026, lots recalled Aug 2026); Apo-Semaglutide (one lot recalled Aug 2026). Semaglutide tablets, weight: none (no oral Wegovy in Health Canada’s drug database). Semaglutide tablets, diabetes: Rybelsus. Semaglutide approved but not marketed: Sevmia, Poviztra, Plosbrio, Aspen-Semaglutide, Semaglutide Injection (Aspen), Sandoz Semaglutide.
Label: Canada's Rybelsus monograph puts tablet absorption at about 1-2%, a little higher than the EU and US figures above.10
Emergency number: 911
Fake and unregulated products, in the Canadian side-effects guide
France
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: none (Wegovy pill not sold in France). Semaglutide tablets, diabetes: none found (Rybelsus not in France’s medicines database).
Label: The answer above applies. The tablet figures come from the EU Rybelsus product information.5
Emergency number: 15 or 112
Fake and unregulated products, in the French side-effects guide
Germany
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy, including 7.2 mg. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy Tablette. Semaglutide tablets, diabetes: Rybelsus.
Label: The answer above applies.
Emergency number: 112
Fake and unregulated products, in the German side-effects guide
India
Sold as: Tirzepatide: Mounjaro, Yurpeak. Semaglutide injection, weight: Wegovy; Poviztra; Noveltreat. Semaglutide injection, diabetes: Ozempic; Obeda (Dr Reddy’s; recalled Jul 2026 over an active-ingredient impurity; on 23 Oct 2026 the company said it planned to relaunch in Nov; resumption not confirmed at 8 Nov 2026; distributors told Reuters it may be discontinued); Sematrinity; GLIPIQ; Semalix (batches recalled Jul 2026); Semanat; Semafull. Semaglutide injection, diabetes and weight: Semaglyn; Mashema; Alterme; Semasize; Obesema; Hepaglide. Semaglutide, diabetes and weight (form not confirmed): Obeda Pro; Obeda Plus (Dr Reddy’s, made by Hetero Labs; in the market from late Jul 2026). Semaglutide injection, use not confirmed: Semanext; Livarise; Sundae. Semaglutide, form and use not confirmed: Samakind; Usema (batches recalled). Semaglutide tablets, weight: not confirmed. Semaglutide tablets, diabetes: Rybelsus; Sembolic; Obeda (tablets not part of the Jul 2026 recall).
Label: The answer above applies. The tablet figures come from the EU and US labels, as we did not open an Indian label for this page.4,5
Emergency number: 112
Fake and unregulated products, in the India side-effects guide
Saudi Arabia
Sold as: Tirzepatide: Mounjaro, Mounjaro KwikPen. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic; Tasylev; Lugyda; Glucentra. Semaglutide tablets, weight: none (Wegovy pill not registered). Semaglutide tablets, diabetes: Rybelsus.
Label: The answer above applies. The tablet figures come from the EU and US labels, as we did not open a Saudi label for this page.4,5
Emergency number: 997 or 911
Fake and unregulated products, in the Saudi side-effects guide
United Arab Emirates
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy pill. Semaglutide tablets, diabetes: Rybelsus.
Label: The answer above applies. The tablet figures come from the EU and US labels, as we did not open a UAE label for this page.4,5
Emergency number: 998 for an ambulance, or 999
Fake and unregulated products, in the UAE side-effects guide
United Kingdom
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy, including 7.2 mg. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy tablets (authorised 11 Jun 2026; retail sale not confirmed). Semaglutide tablets, diabetes: Rybelsus.
Label: The answer above applies.
Emergency number: 999
United States
Sold as: Tirzepatide: Zepbound, Mounjaro. Semaglutide injection, weight: Wegovy, including Wegovy HD 7.2 mg. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy pill. Semaglutide tablets, diabetes: Ozempic tablets; Rybelsus (being discontinued).
Label: The answer above applies.
Emergency number: 911
Contact your prescriber or a doctor if you have used an unauthorised product sold as a GLP-1 and are worried about your health.1
Read the full picture
Related questions
Sources
- Health Canada. Thinking about buying GLP-1 drugs like Ozempic or Mounjaro? Beware of fake or unauthorized products. Public advisory, last updated 21 January 2026. recalls-rappels.canada.ca
- European Medicines Agency. Wegovy: EPAR medicine overview. Last updated 26 August 2026. ema.europa.eu
- US Federal Trade Commission. The truth behind weight loss ads. Consumer advice, February 2025. consumer.ftc.gov
- Novo Nordisk. Rybelsus and Ozempic (semaglutide) tablets: US prescribing information, revised January 2026 (section 12.3). novo-pi.com
- European Medicines Agency. Rybelsus (semaglutide tablets): EU product information (sections 4.2 and 5.2). ema.europa.eu
- Novo Nordisk. Rybelsus 3 mg tablets: UK summary of product characteristics, text revised March 2026. Electronic Medicines Compendium. medicines.org.uk
- Wisbey M. TGA doubles down on fake GLP-1 warnings. newsGP (Royal Australian College of General Practitioners), 4 March 2026. A report of the TGA advisory, which we could not open directly. racgp.org.au
- White CM, Tai Z, Nuzi K. Transdermal “natural GLP-1” dietary supplements violate law and place patients at risk. Ann Pharmacother 2026;60(8):813–6. Abstract read. PMID 41480958
- US National Center for Complementary and Integrative Health (NCCIH, part of NIH). Berberine and weight loss: what you need to know. Last updated November 2023. nccih.nih.gov
- Novo Nordisk Canada. Rybelsus (semaglutide tablets) Product Monograph, 13 July 2026. pdf.hres.ca
- MedlinePlus (US National Library of Medicine). Recognizing medical emergencies: warning signs from the American College of Emergency Physicians. Review date 8 January 2025. medlineplus.gov
Last checked Nov 15, 2026 · Next review due May 15, 2027 · Report an error
How this answer was made. Written by the GLP Guidebook team from the sources above, all checked between Nov 9 and Nov 15, 2026. The “What people report” section summarises public patient forum posts we read; it is not medical evidence, and we never pass on advice that goes against the label. It’s general information, not medical advice. Talk to a doctor, pharmacist or other licensed prescriber before starting, stopping or changing any medicine. In an emergency, call your local emergency number. How we write